Suzhou Highfine Biotech Co., Ltd. (SHE:301393)
China · Delayed Price · Currency is CNY 58.63
-0.97 (-1.63%)
At close: Apr 16, 2026
Suzhou Highfine Biotech Market Cap
Suzhou Highfine Biotech has a market cap or net worth of 6.27 billion as of April 16, 2026. Its market cap has increased by 36.06% in one year.
Market Cap
6.27B
Enterprise Value
5.02B
Revenue
602.26M
Ranking
n/a
PE Ratio
54.82
Stock Price
58.63
Market Cap Chart
Since July 12, 2023, Suzhou Highfine Biotech's market cap has decreased from 11.13B to 6.27B, a decrease of -43.67%. That is a compound annual growth rate of -18.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 6.38B | 17.58% |
| Dec 31, 2025 | 5.42B | 27.01% |
| Dec 31, 2024 | 4.27B | -34.13% |
| Dec 29, 2023 | 6.48B | -41.79% |
| Jul 12, 2023 | 11.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Grandland Group | 6.30B |
| JiangSu Jinji Industrial | 6.29B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 6.29B |
| Zhejiang Int'l Group | 6.28B |
| Guizhou Xinbang Pharmaceutical | 6.28B |
| Shandong Xinneng Taishan Power Generation | 6.27B |
| ShuYu Civilian Pharmacy Corp. | 6.26B |
| Zhejiang Taitan | 6.26B |